Merck

PEDVAXHIB

Manufacturer:

Merck

Pedvaxhib HCPCS:

90647

HCPCS Code Descriptor:

Hemophilus influenza B vaccine (Hib), PRP-OMP conjugate, 3 dose schedule for intramuscular use.

Category:

CPT Drug Code

Pedvaxhib NDCs:

00006-4897-00

Primary Type:

Vaccine-HIB

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intramuscular

Pedvaxhib CPT Codes:

Potential CPT administration codes for Pedvaxhib can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00006-4897-00

About Pedvaxhib:

PEDVAXHIB is a Vaccine-HIB drug manufactured by Merck and administered via the Intramuscular route of administration. The CPT Drug Code: 90647 is aligned to the drug PEDVAXHIB.

ACCESS PRICING AND MORE BY REGISTERING

90647 Added Date:

NA

90647 Effective Date:

NA

90647 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Pedvaxhib billing and coding information.
Our team did not identify a source for Pedvaxhib patient assistance information. Please reach out to our team if you feel that this is a mistake.
PEDVAXHIB prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for PEDVAXHIB. Please check back in a few weeks.